Close Menu

NEW YORK — Arcis Biotechnology said today that it has signed a global distribution agreement for its nucleic acid sample prep products with Opentrons.

Under the terms of the deal, New York City-based Opentrons will offer Arcis' line of nucleic acid extraction and preservation products with its automated OT-2 lab robot platform to customers worldwide. Additional terms were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The first reported coronavirus cases in Europe and the US might not be related to the subsequent outbreaks in those areas, according to the New York Times.

According to NPR, there's a growing shortage of machines to run SARS-CoV-2 tests.

The Wall Street Journal and Kaiser Health News report that antibody testing for SARS-CoV-2 has led to further confusion.

In Nature this week: the largest known collection of human genetic variants, and more.